As a general rule in the medical device sector, accelerated aging data is expected to be ultimately backed up with real-time data. Consequently, you would still generally need to have real-time data to support the 6-year shelf life (such as by continuing your 4-year real-time study into a 6-year study) even though you can, in the interim, label with the 6-year expiration date based on the completed 6-year accelerated data.
------------------------------
Kevin Randall, ASQ CQA, RAC (Europe, U.S., Canada)
Principal Consultant
Ridgway, CO
United States
© Copyright 2023 by ComplianceAcuity, Inc. All rights reserved.
------------------------------
Original Message:
Sent: 22-Feb-2023 11:52
From: Anonymous Member
Subject: Shelf life extension, combining tests
This message was posted by a user wishing to remain anonymous
We would like to extend the shelf life of our product to 6 years.
Today we have real-time aged data for 4 years and we are considering accelerating aging for the last 2 years.
Are there any issues with having a mixture of real-time and accelerated aging to reach a total of 6 years?